or Try an Advanced Search...

    Kidney Disease Stocks List

    Symbol Grade Name % Change
    CALT B Calliditas Therapeutics AB -0.10
    SNY B Sanofi 1.64
    LGND B Ligand Pharmaceuticals Incorporated 2.02
    XBIO C Xenetic Biosciences, Inc. 7.12
    TVTX C Travere Therapeutics, Inc. -0.63
    DMAC C DiaMedica Therapeutics Inc. 0.35
    AZN C Astrazeneca PLC 0.70
    TRIB C Trinity Biotech plc -4.67
    BAX C Baxter International Inc. 5.28
    RMTI D Rockwell Medical, Inc. -2.71
    View As Page of Charts
    Related Industries: Biotechnology Data Storage Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
    Related Stock Lists: Biopharmaceutical Chronic Kidney Disease Dialysis Medicine Renal Disease Acid Biotechnology End Stage Renal Disease Life Sciences Pharmacy Phosphates Stage Renal Disease Anemia Antibodies Cancer Clinical Medicine Clopidogrel Glucose Health Sciences Hemodialysis

    Related ETFs - A few ETFs which own one or more of the above listed Kidney Disease stocks.

    Symbol Grade Name Weight
    VTI A Vanguard Total Stock Market ETF 0.0
    VXF C Vanguard Extended Market ETF 0.0
    View all Kidney Disease ETFs...
    Compare ETFs
    Compare VTI to VXF

        Kidney Disease Stocks Recent News

        Date Stock Title
        Jul 5 BAX Carlyle in talks to buy Baxter's kidney care unit, source says
        Jul 5 BAX Baxter gains amid report in talks to sell kidney care spinoff to Carlyle for $4B
        Jul 5 AZN AstraZeneca & Aptamer partner to bolster targeted siRNA therapies
        Jul 5 AZN AstraZeneca’s Tagrisso plus chemotherapy wins EU approval for NSCLC
        Jul 5 AZN AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
        Jul 5 AZN Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
        Jul 5 SNY Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
        Jul 5 AZN Investors in AstraZeneca (LON:AZN) have seen strong returns of 115% over the past five years
        Jul 5 SNY Dupixent “addresses current gap” in COPD biologics landscape
        Jul 5 AZN What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
        Jul 4 SNY French State Investment Firm Eyes Stake in Sanofi Consumer Unit
        Jul 4 CALT Launch of Phase 3 clinical trial with Nefecon in Japan
        Jul 3 SNY Update: Market Chatter: Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division
        Jul 3 SNY Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit
        Jul 3 SNY Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
        Jul 3 SNY Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
        Jul 3 SNY Sanofi, Regeneron win EU label expansion for Dupixent in COPD
        Jul 3 SNY EMA approves Sanofi’s Dupixent for COPD treatment in adults
        Jul 3 SNY Update: Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
        Jul 3 SNY Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
        Related Industries: Biotechnology Data Storage Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
        Related Stock Lists: Kidney Biotechnology Diabetic Nephropathy Organ Systems Acute Kidney Injury Acute Myeloid Leukemia Alport Syndrome Anemia Autosomal Dominant Polycystic Kidney Disease Biopharmaceutical Chemical Entity Chronic Kidney Disease Diabetic Kidney Disease Dialysis Drug Therapies Endometrial Cancer Erythropoietin FDA Focal Segmental Glomerulosclerosis Glomerulosclerosis
        Kidney Disease

        Kidney disease is a condition in which the kidneys are damaged and unable to filter waste and toxins from the blood. This can lead to a buildup of waste and toxins in the body, which can cause a variety of symptoms, including fatigue, nausea, loss of appetite, and swelling in the hands and feet. In severe cases, kidney disease can lead to kidney failure, which requires dialysis or a kidney transplant.

        Browse All Tags